pediapharm Chef de file pharmaceutique en pédiatrie au Canada

Canada's Leading Pediatric Pharmaceutical Company

What's new

Pediapharm Announces Q2 Results – Record Adjusted EBITDA, Record Revenue and 13th Consecutive Year-Over-Year Quarterly Revenue Growth

Read more >

Pediapharm Announces Closing of Transformative Acquisitions, Diversifying and Expanding the Platform for Future Growth

Read more >

Pediapharm Announces Closing of Subscription Receipt Offering for Total Gross Proceeds of $62 Million

Read more >

Products

Stock – PDP.V